Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Allogene anti-CD19 CAR-T-celtherapie voor gerecidiveerde of refractaire B-cel ALL
dec 2022 | Leukemie